UBS Group’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$351 Sell
1,252
-6,296
-83% -$1.77K ﹤0.01% 8533
2025
Q1
$2.34K Buy
7,548
+5,835
+341% +$1.81K ﹤0.01% 8038
2024
Q4
$1.29K Sell
1,713
-11,060
-87% -$8.3K ﹤0.01% 8026
2024
Q3
$16K Sell
12,773
-9,770
-43% -$12.2K ﹤0.01% 6282
2024
Q2
$28.2K Buy
22,543
+19,652
+680% +$24.6K ﹤0.01% 5949
2024
Q1
$3.24K Sell
2,891
-6,462
-69% -$7.24K ﹤0.01% 6586
2023
Q4
$12.4K Buy
9,353
+9,253
+9,253% +$12.3K ﹤0.01% 6145
2023
Q3
$106 Sell
100
-1,141
-92% -$1.21K ﹤0.01% 7721
2023
Q2
$1.38K Sell
1,241
-4,173
-77% -$4.63K ﹤0.01% 6851
2023
Q1
$8.01K Buy
5,414
+1,045
+24% +$1.55K ﹤0.01% 6665
2022
Q4
$11K Sell
4,369
-4,122
-49% -$10.4K ﹤0.01% 7252
2022
Q3
$27K Buy
+8,491
New +$27K ﹤0.01% 5899
2022
Q2
Sell
-1,500
Closed -$9K 9300
2022
Q1
$9K Sell
1,500
-24,776
-94% -$149K ﹤0.01% 7481
2021
Q4
$235K Buy
26,276
+9,560
+57% +$85.5K ﹤0.01% 4514
2021
Q3
$163K Sell
16,716
-13,760
-45% -$134K ﹤0.01% 4420
2021
Q2
$251K Sell
30,476
-7,075
-19% -$58.3K ﹤0.01% 4183
2021
Q1
$358K Buy
37,551
+31,158
+487% +$297K ﹤0.01% 4147
2020
Q4
$59K Buy
6,393
+1,454
+29% +$13.4K ﹤0.01% 5044
2020
Q3
$67K Sell
4,939
-17,828
-78% -$242K ﹤0.01% 4597
2020
Q2
$440K Buy
22,767
+22,537
+9,799% +$436K ﹤0.01% 3493
2020
Q1
$2K Buy
+230
New +$2K ﹤0.01% 6677
2019
Q4
Sell
-687
Closed -$1K 7030
2019
Q3
$1K Sell
687
-7,111
-91% -$10.4K ﹤0.01% 6849
2019
Q2
$6K Buy
7,798
+6,384
+451% +$4.91K ﹤0.01% 6425
2019
Q1
$2K Sell
1,414
-3,091
-69% -$4.37K ﹤0.01% 6587
2018
Q4
$7K Buy
4,505
+1,505
+50% +$2.34K ﹤0.01% 6471
2018
Q3
$8K Buy
3,000
+792
+36% +$2.11K ﹤0.01% 6345
2018
Q2
$9K Sell
2,208
-2,656
-55% -$10.8K ﹤0.01% 6258
2018
Q1
$11K Buy
4,864
+3,927
+419% +$8.88K ﹤0.01% 5916
2017
Q4
$2K Buy
+937
New +$2K ﹤0.01% 6619